154 related articles for article (PubMed ID: 22971573)
1. Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling.
Ahmad A; Sarkar SH; Aboukameel A; Ali S; Biersack B; Seibt S; Li Y; Bao B; Kong D; Banerjee S; Schobert R; Padhye SB; Sarkar FH
Carcinogenesis; 2012 Dec; 33(12):2450-6. PubMed ID: 22971573
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-inducing effect of garcinol is mediated by NF-kappaB signaling in breast cancer cells.
Ahmad A; Wang Z; Ali R; Maitah MY; Kong D; Banerjee S; Padhye S; Sarkar FH
J Cell Biochem; 2010 Apr; 109(6):1134-41. PubMed ID: 20108249
[TBL] [Abstract][Full Text] [Related]
3. Garcinol, a polyisoprenylated benzophenone modulates multiple proinflammatory signaling cascades leading to the suppression of growth and survival of head and neck carcinoma.
Li F; Shanmugam MK; Chen L; Chatterjee S; Basha J; Kumar AP; Kundu TK; Sethi G
Cancer Prev Res (Phila); 2013 Aug; 6(8):843-54. PubMed ID: 23803415
[TBL] [Abstract][Full Text] [Related]
4. Ganoderic acids suppress growth and angiogenesis by modulating the NF-κB signaling pathway in breast cancer cells.
Li F; Wang Y; Wang X; Li J; Cui H; Niu M
Int J Clin Pharmacol Ther; 2012 Oct; 50(10):712-21. PubMed ID: 22762853
[TBL] [Abstract][Full Text] [Related]
5. Garcinol regulates EMT and Wnt signaling pathways in vitro and in vivo, leading to anticancer activity against breast cancer cells.
Ahmad A; Sarkar SH; Bitar B; Ali S; Aboukameel A; Sethi S; Li Y; Bao B; Kong D; Banerjee S; Padhye SB; Sarkar FH
Mol Cancer Ther; 2012 Oct; 11(10):2193-201. PubMed ID: 22821148
[TBL] [Abstract][Full Text] [Related]
6. Garcinol modulates tyrosine phosphorylation of FAK and subsequently induces apoptosis through down-regulation of Src, ERK, and Akt survival signaling in human colon cancer cells.
Liao CH; Sang S; Ho CT; Lin JK
J Cell Biochem; 2005 Sep; 96(1):155-69. PubMed ID: 16052481
[TBL] [Abstract][Full Text] [Related]
7. Blockage of interleukin-6 signaling with 6-amino-4-quinazoline synergistically induces the inhibitory effect of bortezomib in human U266 cells.
Park J; Ahn KS; Bae EK; Kim BS; Kim BK; Lee YY; Yoon SS
Anticancer Drugs; 2008 Sep; 19(8):777-82. PubMed ID: 18690088
[TBL] [Abstract][Full Text] [Related]
8. Garcinol inhibits cancer stem cell-like phenotype via suppression of the Wnt/β-catenin/STAT3 axis signalling pathway in human non-small cell lung carcinomas.
Huang WC; Kuo KT; Adebayo BO; Wang CH; Chen YJ; Jin K; Tsai TH; Yeh CT
J Nutr Biochem; 2018 Apr; 54():140-150. PubMed ID: 29414668
[TBL] [Abstract][Full Text] [Related]
9. Garcinol-induced apoptosis in prostate and pancreatic cancer cells is mediated by NF- kappaB signaling.
Ahmad A; Wang Z; Wojewoda C; Ali R; Kong D; Maitah MY; Banerjee S; Bao B; Padhye S; Sarkar FH
Front Biosci (Elite Ed); 2011 Jun; 3(4):1483-92. PubMed ID: 21622152
[TBL] [Abstract][Full Text] [Related]
10. Nicotine-induced human breast cancer cell proliferation attenuated by garcinol through down-regulation of the nicotinic receptor and cyclin D3 proteins.
Chen CS; Lee CH; Hsieh CD; Ho CT; Pan MH; Huang CS; Tu SH; Wang YJ; Chen LC; Chang YJ; Wei PL; Yang YY; Wu CH; Ho YS
Breast Cancer Res Treat; 2011 Jan; 125(1):73-87. PubMed ID: 20229177
[TBL] [Abstract][Full Text] [Related]
11. Effects of garcinol and its derivatives on intestinal cell growth: Inhibitory effects and autoxidation-dependent growth-stimulatory effects.
Hong J; Kwon SJ; Sang S; Ju J; Zhou JN; Ho CT; Huang MT; Yang CS
Free Radic Biol Med; 2007 Apr; 42(8):1211-21. PubMed ID: 17382202
[TBL] [Abstract][Full Text] [Related]
12. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effects of signal transducer and activator of transcription 3 siRNA on human breast cancer in xenograft mice.
Yang Z; Cai JH; Xie SJ; Li GX; Song WQ; Yan QH; Yan L; Zhang F
Chin Med J (Engl); 2011 Jun; 124(12):1854-61. PubMed ID: 21740845
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
15. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
[TBL] [Abstract][Full Text] [Related]
16. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative and anti-invasive effects of garcinol from
Duan YT; Yang XA; Fang LY; Wang JH; Liu Q
Pharmazie; 2018 Jul; 73(7):413-417. PubMed ID: 30001777
[TBL] [Abstract][Full Text] [Related]
18. Biophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lung tissue.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2008 Mar; 7(1):42-50. PubMed ID: 18292594
[TBL] [Abstract][Full Text] [Related]
19. Curcumin suppresses constitutive activation of STAT-3 by up-regulating protein inhibitor of activated STAT-3 (PIAS-3) in ovarian and endometrial cancer cells.
Saydmohammed M; Joseph D; Syed V
J Cell Biochem; 2010 May; 110(2):447-56. PubMed ID: 20235152
[TBL] [Abstract][Full Text] [Related]
20. Antitumor activity of a novel small molecule STAT3 inhibitor against a human lymphoma cell line with high STAT3 activation.
Ashizawa T; Miyata H; Ishii H; Oshita C; Matsuno K; Masuda Y; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Akiyama Y
Int J Oncol; 2011 May; 38(5):1245-52. PubMed ID: 21369699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
